Licio Collavin
Impact in
- Cancer Research top 1%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Oncology top 2%
- Cancer-related Molecular Pathways
Papers in
-
- RNA modifications and cancer 10
- Ubiquitin and proteasome pathways 8
- Epigenetics and DNA Methylation 6
- Cell death mechanisms and regulation 5
- RNA Research and Splicing 4
- Oncology 22
- Cancer-related Molecular Pathways 21
- Co-authors
- Giannino Del Sal (20 shared papers)Fiamma Mantovani (3 shared papers)Andrea Lunardi (4 shared papers)Claudio Santoro (2 shared papers)S. Zucchelli (3 shared papers)Stefano Gustincich (3 shared papers)Isidró Ferrer (2 shared papers)Marco Napoli (1 shared paper)
- Journals
- Cell Death and Differentiation (6 papers)Proceedings of the National Academy of Sciences (5 papers)Journal of Biological Chemistry (3 papers)Oncogene (2 papers)Cancers (2 papers)
- Partner nations
- ItalyUnited StatesSwitzerland
In The Last Decade
Licio Collavin
37 papers receiving 3.2k citations
Licio Collavin's Hit Papers
Peers
Comparison fields: 5 of 115
- Cancer Research 1.1k
- Oncology 910
- Molecular Biology 2.4k
- Cell Biology 306
- Biotechnology 148
Countries citing papers authored by Licio Collavin
This map shows the geographic impact of Licio Collavin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Licio Collavin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Licio Collavin more than expected).
Fields of papers citing papers by Licio Collavin
This network shows the impact of papers produced by Licio Collavin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Licio Collavin. The network helps show where Licio Collavin may publish in the future.
Co-authors
The 25 scholars most cited alongside Licio Collavin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Long non-coding antisense RNA controls Uchl1 translation through an embedded SINEB2 repeat Hit paper breakdown → | 2012 | 813 |
| 2 | Mutant p53 as a guardian of the cancer cell Hit paper breakdown → | 2018 | 581 |
| 3 | 2012 | 234 | |
| 4 | 2012 | 203 | |
| 5 | 2010 | 190 | |
| 6 | 2014 | 135 | |
| 7 | 1998 | 88 | |
| 8 | 1997 | 83 | |
| 9 | 1994 | 74 | |
| 10 | 2019 | 70 | |
| 11 | 2003 | 68 | |
| 12 | 2004 | 63 | |
| 13 | 2004 | 60 | |
| 14 | 2010 | 56 | |
| 15 | 2016 | 50 | |
| 16 | 2004 | 47 | |
| 17 | 1999 | 45 | |
| 18 | 2012 | 44 | |
| 19 | 2017 | 41 | |
| 20 | 2011 | 36 |
About Licio Collavin
Licio Collavin is a scholar working on Molecular Biology, Oncology, Cancer Research, Cell Biology and Biotechnology, having authored 37 papers that have together received 3.3k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (21 papers), RNA modifications and cancer (10 papers), Ubiquitin and proteasome pathways (8 papers), Epigenetics and DNA Methylation (6 papers), Cell death mechanisms and regulation (5 papers), RNA Research and Splicing (4 papers), Cancer Research and Treatments (4 papers) and NF-κB Signaling Pathways (3 papers). The work is most often cited by research in Cancer Research (1.1k citations), Oncology (910 citations), Molecular Biology (2.4k citations), Cell Biology (306 citations) and Biotechnology (148 citations). Licio Collavin has collaborated with scholars based in Italy, United States and Switzerland. Frequent co-authors include Giannino Del Sal, Fiamma Mantovani, Andrea Lunardi, Claudio Santoro, S. Zucchelli, Stefano Gustincich, Isidró Ferrer, Marco Napoli, Dawid Walerych and Marta Biagioli. Their work appears in journals such as Cell Death and Differentiation, Proceedings of the National Academy of Sciences, Journal of Biological Chemistry, Oncogene and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.